Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy in the elective treatment of recurrent variceal bleeding

Journal of International Medical Research

Volumn 38, Issue 3, 2010, Pages 1121-1133

  Popovic P ^a   Stabuc B ^a   Skok, P ^b   Surlan M ^c  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE MARIBOR   (Slovenia)

^c UNIVERSITY OF MARIBOR   (Slovenia)

Author keywords

Endoscopic sclerotherapy; Portal hypertension; Rebleeding rate; Recurrent variceal bleeding; Transjugular intrahepatic portosystemic shunt; Treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; BILIRUBIN;

ABDOMINAL BLEEDING; ADULT; ANESTHESIA COMPLICATION; ARTICLE; BLEEDING; BRAIN DISEASE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE SEVERITY; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS VARICES; FALSE ANEURYSM; FEMALE; GASTROESOPHAGUS VARICES BLEEDING; HEART FAILURE; HEMATOMA; HEPATIC ENCEPHALOPATHY; HUMAN; INTERMETHOD COMPARISON; LIVER CIRRHOSIS; LIVER FAILURE; LIVER VEIN OBSTRUCTION; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; PORTAL HYPERTENSION; RECURRENT DISEASE; STOMACH VARICES; SURVIVAL RATE; THROMBOCYTE COUNT; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT OUTCOME; AGED; COMPARATIVE STUDY; COMPLICATION; DEVICE FAILURE; EPIDEMIOLOGY; ESOPHAGEAL AND GASTRIC VARICES; ESOPHAGOSCOPY; HYPERTENSION, PORTAL; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; SCLEROTHERAPY; SLOVENIA; STENT;

AGED; EQUIPMENT FAILURE; ESOPHAGEAL AND GASTRIC VARICES; ESOPHAGOSCOPY; FEMALE; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RETROSPECTIVE STUDIES; SCLEROTHERAPY; SLOVENIA; STENTS; SURVIVAL RATE;

EID: 77954789287     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800341     Document Type: Article

References (30)

1. Jalan R, Hayes PC: UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut 2000; 46(suppl 3 -4): III1-III15.
2. Luketi VA, Sanyal AJ: Esophageal varices. II. TIPS (transjugular intrahepatic portosystemic shunt) and surgical therapy. Gastroenterol Clin North Am 2000; 29: 387-421.
3. Wong F, Blendis L: An advance in the treatment of portal hypertension. Gastroenterology 2000; 118: 802-803.
4. Singh P, Pooran N, Indaram A, et al: Combined ligation and sclerotherapy versus ligation alone for secondary prophylaxis of esophageal variceal bleeding: a meta-analysis. Am J Gastroenterol 2002; 97: 623-629.
5. Kravetz D: Prevention of recurrent esophageal variceal hemorrhage: review and current recommendations. J Clin Gastroenterol 2007; 41(suppl 3): S318-S322.
6. Colapinto RF, Stronell RD, Birch SJ, et al: Creation of an intrahepatic portosystemic shunt with a Grüntzig balloon catheter. Can Med Assoc J 1982; 126: 267-268.
7. Sahagun G, Benner KG, Saxon R, et al: Outcome of 100 patients after transjugular intrahepatic portosystemic shunt (TIPS) for variceal hemorrhage. Am J Gastroenterol 1997; 92: 1444-1452.
8. Boyer TD: Transjugular intrahepatic portosystemic shunt: current status. Gastroenterology 2003; 124: 1700-1710.
9. Colombato L: The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension. J Clin Gastroenterol 2007; 41(suppl 3): S344-S351.
10. Hassoun Z, Pomier-Layrargues G: The transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension. Eur J Gastroenterol Hepatol 2004; 16: 1-4.
11. Ferral H, Patel NH: Selection criteria for patients undergoing transjugular intrahepatic portosystemic shunt procedure: current status. J Vasc Interv Radiol 2005; 16: 449-455.
12. Barton RE, Rosch J, Saxon RR, et al: TIPS: Short and long term results: A survey of 1750 patients. Semin Interv Radiol 1995; 12: 364-367.
13. LaBerge JM, Somberg KA, Lake JR, et al: Two year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology 1995; 108: 1143-1151.
14. Bilbao JI, Quiroga J, Herrero JI, et al: Transjugular intrahepatic portosystemic shunt (TIPS): current status and future possibilities. Cardiovasc Intervent Radiol 2002; 25: 251-269.
15. Luca A, D'Amico G, La Galla R, et al: TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials. Radiology 1999; 212: 411-421.
16. Papatheodoridis GV, Goulis J, Leandro G, et al: Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: a meta-analysis. Hepatology 1999; 30: 612-622.
17. Cejna M, Peck-Radosavljevic M, Thurnher SA, et al: Creation of transjugular intrahepatic portosystemic shunts with stent-grafts: initial experiences with a polytetrafluoroethylene-covered nitinol endoprosthesis. Radiology 2001; 221: 437-446.
18. Cabrera J, Maynar M, Granados R, et al: Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal haemorrhage. Gastroenterology 1996; 110: 832-839.
19. Rössle M, Deibert P, Haag K, et al: Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for the prevention of variceal rebleeding. Lancet 1997; 349: 1043-1049.
20. Cello JP, Ring EJ, Olcott EW, et al: Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal haemorrhage. A randomized controlled trial. Ann Intern Med 1997; 126: 858-865.
21. Sanyal AJ, Freedman AM, Luketic VA, et al: Transjugular intrahepatic portosystemic shunt compared with endoscopic sclerotherapy for the prevention of recurrent variceal haemorrhage: a randomized controlled trial. Ann Intern Med 1997; 126: 849-857.
22. Sauer P, Theilmann L, Stremmel W, et al: Transjugular intrahepatic portosystemic shunt versus sclerotherapy plus propranolol for variceal rebleeding. Gastroenterology 1997; 113: 1623-1631.
23. Merli M, Salerno F, Riggio O, et al: Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.). Hepatology 1998; 27: 48-53.
24. Garcia-Villarreal L, Martinez-Lagares F, Sierra A, et al: Transjugular intrahepatic porto-systemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after variceal hemorrhage. Hepatology 1999; 29: 27-32.
25. Groupe d'Etudes des Anastamoses Intr-Hepatiques (Toulouse BLNCPF): TIPS versus sclerotherapy +propanolol in the prevention of variceal rebleeding: preliminary results of a multicenter randomized trial. Hepatology 1995; 22(suppl): 229A [abstract].
26. Sarfeh IJ, Rypins EB, Mason GR: A systematic appraisal of portacaval H-graft diameters. Clinical and hemodynamic perspectives. Ann Surg 1986; 204: 356-363.
27. Johansen K: Partial portal decompression for variceal hemorrhage. Am J Surg 1989; 157: 479-482.
28. LaBerge JM: Histology of transjugular intrahepatic portosystemic shunts. Semin Interv Radiol 1995; 12: 384-388.
29. Somberg KA, Riegler JL, LaBerge JM, et al: Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors. Am J Gastroenterol 1995; 90: 549-555.
30. Blei TA, Cordoba J: Hepatic encephalopathy. Am J Gastroenterol 2001; 96: 1968-1976.